Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7404539 | 0.87 | ACHE (0.46) | ACHEEPHX1 | |
| SCHEMBL8141861 | 0.85 | EPHX1 (0.44) | ACHENPC1RAB9ASMN1; SMN2EPHX1 | |
| SCHEMBL4685971 | 0.85 | SIRT2 (0.43) | NPC1RAB9ASMN1; SMN2EPHX1 | |
| SCHEMBL7812490 | 0.84 | SIRT2 (0.44) | ACHENPC1RAB9ASMN1; SMN2EPHX1 | |
| SCHEMBL24096149 | 0.83 | EPHX1 (0.51) | ACHEEPHX1 | |
| SCHEMBL7278916 | 0.83 | RAB9A (0.42) | ACHENPC1RAB9ASMN1; SMN2EPHX1 | |
| SCHEMBL7278909 | 0.83 | RAB9A (0.42) | ACHENPC1RAB9ASMN1; SMN2EPHX1 | |
| SCHEMBL17099347 | 0.82 | ACHE (0.41) | ACHEEPHX1 | |
| SCHEMBL18699093 | 0.82 | ACHE (0.53) | ACHENPC1RAB9ASMN1; SMN2EPHX1 | |
| SCHEMBL8872226 | 0.81 | ECE1 (0.43) | ACHENPC1RAB9ASMN1; SMN2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0574135-A1 | Process for producing peptide derivatives and salts thereof | JAPAN ENERGY CORPORATION (JP) | 1993-12-15 | — | — | EP | disclosed |